| Year |
Citation |
Score |
| 2020 |
de Lima JM, Morand GB, Macedo CCS, Diesel L, Hier MP, Mlynarek A, Kowalski LP, Maschietto M, Alaoui-Jamali MA, Silva SDD. Ndrg1 Deficiency is associated with Regional Metastasis in Oral Cancer by inducing Epithelial-Mesenchymal transition. Carcinogenesis. PMID 32112078 DOI: 10.1093/Carcin/Bgaa017 |
0.407 |
|
| 2019 |
Sirois I, Aguilar-Mahecha A, Lafleur J, Fowler E, Vu V, Scriver M, Buchanan M, Chabot C, Ramanathan A, Balachandran B, Legare S, Przybytkowski E, Lan C, Krzemien U, Cavallone L, ... ... Alaoui-Jamali M, et al. A unique morphological phenotype in chemoresistant triple negative breast cancer reveals metabolic reprogramming and PLIN4 expression as a molecular vulnerability. Molecular Cancer Research : McR. PMID 31537618 DOI: 10.1158/1541-7786.Mcr-19-0264 |
0.36 |
|
| 2019 |
Shorstova T, Marques M, Su J, Johnston J, Kleinman CL, Hamel N, Huang S, Alaoui-Jamali MA, Foulkes WD, Witcher M. SWI/SNF-compromised cancers are susceptible to bromodomain inhibitors. Cancer Research. PMID 30877105 DOI: 10.1158/0008-5472.Can-18-1545 |
0.386 |
|
| 2019 |
Chang CH, Bijian K, Wernic D, Su J, da Silva SD, Yu H, Qiu D, Asslan M, Alaoui-Jamali MA. A novel orally available seleno-purine molecule suppresses triple-negative breast cancer cell proliferation and progression to metastasis by inducing cytostatic autophagy. Autophagy. PMID 30773992 DOI: 10.1080/15548627.2019.1582951 |
0.396 |
|
| 2019 |
Guo Q, Li VZ, Nichol JN, Huang F, Yang W, Preston SEJ, Talat Z, Lefrère H, Yu H, Zhang G, Basik M, Gonçalves C, Zhan Y, Plourde D, Su J, ... ... Alaoui-Jamali MA, et al. MNK1/NODAL signaling promotes invasive progression of breast ductal carcinoma in situ. Cancer Research. PMID 30659022 DOI: 10.1158/0008-5472.Can-18-1602 |
0.401 |
|
| 2018 |
Marques M, Jangal M, Wang LC, Kazanets A, da Silva SD, Zhao T, Lovato A, Yu H, Jie S, Del Rincon S, Mackey J, Damaraju S, Alaoui-Jamali M, Witcher M. Oncogenic activity of poly (ADP-ribose) glycohydrolase. Oncogene. PMID 30459355 DOI: 10.1038/S41388-018-0568-6 |
0.417 |
|
| 2018 |
Daniela da Silva S, Xu B, Maschietto M, Marchi FA, Alkailani MI, Bijian K, Xiao D, Alaoui-Jamali MA. TRAF2 COOPERATES WITH FOCAL ADHESION SIGNALING TO REGULATE CANCER CELL SUSCEPTIBILITY TO ANOIKIS. Molecular Cancer Therapeutics. PMID 30373932 DOI: 10.1158/1535-7163.Mct-17-1261 |
0.404 |
|
| 2018 |
Li L, Guturi KKN, Gautreau B, Patel PS, Saad A, Morii M, Mateo F, Palomero L, Barbour H, Gomez A, Ng D, Kotlyar M, Pastrello C, Jackson HW, Khokha R, ... ... Alaoui-Jamali M, et al. Ubiquitin ligase RNF8 suppresses Notch signaling to regulate mammary development and tumorigenesis. The Journal of Clinical Investigation. PMID 30222135 DOI: 10.1172/Jci120401 |
0.379 |
|
| 2018 |
Carnielli CM, Macedo CCS, De Rossi T, Granato DC, Rivera C, Domingues RR, Pauletti BA, Yokoo S, Heberle H, Busso-Lopes AF, Cervigne NK, Sawazaki-Calone I, Meirelles GV, Marchi FA, Telles GP, ... ... Alaoui-Jamali MA, et al. Combining discovery and targeted proteomics reveals a prognostic signature in oral cancer. Nature Communications. 9: 3598. PMID 30185791 DOI: 10.1038/S41467-018-05696-2 |
0.328 |
|
| 2018 |
Ghashghaei M, Muanza T, Alaoui-Jamali M, Paliouras M, Niazi MT. Abstract 858: Enzalutamide versus abiraterone as a radiosensitizer in hormone-sensitive prostate cancer cells Cancer Research. 78: 858-858. DOI: 10.1158/1538-7445.Am2018-858 |
0.379 |
|
| 2018 |
Soares Macedo CC, Rodrigues PC, Salo TA, Paes Leme AF, Alaoui-Jamali M, Da Silva SD, Coletta RD. Fascin-Dependent Invadopodia Formation in Oral Squamous Cell Carcinoma Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 126: e162. DOI: 10.1016/J.Oooo.2018.02.646 |
0.305 |
|
| 2017 |
Rodrigues PC, Sawazaki-Calone I, Ervolino de Oliveira C, Soares Macedo CC, Dourado MR, Cervigne NK, Miguel MC, Ferreira do Carmo A, Lambert DW, Graner E, Daniela da Silva S, Alaoui-Jamali MA, Paes Leme AF, Salo TA, Coletta RD. Fascin promotes migration and invasion and is a prognostic marker for oral squamous cell carcinoma. Oncotarget. 8: 74736-74754. PMID 29088820 DOI: 10.18632/Oncotarget.20360 |
0.376 |
|
| 2017 |
Zhan Y, Guo J, Yang W, Goncalves C, Rzymski T, Dreas A, Żyłkiewicz E, Mikulski M, Brzózka K, Golas A, Kong Y, Ma M, Huang F, Huor B, Guo Q, ... ... Alaoui-Jamali MA, et al. MNK1/2 inhibition limits oncogenicity and metastasis of KIT-mutant melanoma. The Journal of Clinical Investigation. PMID 29035277 DOI: 10.1172/Jci91258 |
0.368 |
|
| 2017 |
Bijian K, Kaldre D, Wang TT, Bouttier M, Boucher A, Alaoui-Jamali M, White JH, Gleason JL. Efficacy of Hybrid Vitamin D Receptor Agonist/Histone Deacetylase Inhibitors in Vitamin D-Resistant Triple-Negative 4T1 Breast Cancer. The Journal of Steroid Biochemistry and Molecular Biology. PMID 28847749 DOI: 10.1016/J.Jsbmb.2017.08.010 |
0.327 |
|
| 2017 |
Hilmi K, Jangal M, Marques M, Zhao T, Saad A, Zhang C, Luo VM, Syme A, Rejon C, Yu Z, Krum A, Fabian MR, Richard S, Alaoui-Jamali M, Orthwein A, et al. CTCF facilitates DNA double-strand break repair by enhancing homologous recombination repair. Science Advances. 3: e1601898. PMID 28560323 DOI: 10.1126/Sciadv.1601898 |
0.348 |
|
| 2017 |
Chang CH, Bijian K, Qiu D, Su J, Saad A, Dahabieh MS, Miller WH, Alaoui-Jamali MA. Endosomal sorting and c-Cbl targeting of paxillin to autophagosomes regulate cell-matrix adhesion turnover in human breast cancer cells. Oncotarget. PMID 28415719 DOI: 10.18632/Oncotarget.16105 |
0.394 |
|
| 2017 |
Hilmi K, Zhang C, Yu Z, Saad A, Richard S, McCaffrey L, Alaoui-Jamali MA, Witcher M. Abstract A12: CTCF facilitates DNA double-strand break repair by homologous recombination Molecular Cancer Research. 15. DOI: 10.1158/1557-3125.Dnarepair16-A12 |
0.361 |
|
| 2016 |
Kahouli I, Malhotra M, Westfall S, Alaoui-Jamali MA, Prakash S. Design and validation of an orally administrated active L. fermentum-L. acidophilus probiotic formulation using colorectal cancer Apc (Min/+) mouse model. Applied Microbiology and Biotechnology. PMID 27837314 DOI: 10.1007/S00253-016-7885-X |
0.373 |
|
| 2016 |
Nassour H, Wang Z, Saad A, Papaluca A, Brosseau N, Affar EB, Alaoui-Jamali MA, Ramotar D. Peroxiredoxin 1 interacts with and blocks the redox factor APE1 from activating interleukin-8 expression. Scientific Reports. 6: 29389. PMID 27388124 DOI: 10.1038/Srep29389 |
0.376 |
|
| 2016 |
Bakkar A, Alshalalfa M, Petersen LF, Abou-Ouf H, Al-Mami A, Hegazy SA, Feng F, Alhajj R, Bijian K, Alaoui-Jamali MA, Bismar TA. microRNA 338-3p exhibits tumor suppressor role and its down-regulation is associated with adverse clinical outcome in prostate cancer patients. Molecular Biology Reports. PMID 26907180 DOI: 10.1007/S11033-016-3948-4 |
0.321 |
|
| 2015 |
da Silva SD, Marchi FA, Xu B, Bijian K, Alobaid F, Mlynarek A, Rogatto SR, Hier M, Kowalski LP, Alaoui-Jamali MA. Predominant Rab-GTPase amplicons contributing to oral squamous cell carcinoma progression to metastasis. Oncotarget. PMID 26110570 DOI: 10.18632/Oncotarget.4277 |
0.399 |
|
| 2015 |
Alaoui-Jamali MA, Morand GB, da Silva SD. ErbB polymorphisms: insights and implications for response to targeted cancer therapeutics. Frontiers in Genetics. 6: 17. PMID 25699077 DOI: 10.3389/Fgene.2015.00017 |
0.323 |
|
| 2015 |
Peña-Hernández R, Marques M, Hilmi K, Zhao T, Saad A, Alaoui-Jamali MA, del Rincon SV, Ashworth T, Roy AL, Emerson BM, Witcher M. Genome-wide targeting of the epigenetic regulatory protein CTCF to gene promoters by the transcription factor TFII-I. Proceedings of the National Academy of Sciences of the United States of America. 112: E677-86. PMID 25646466 DOI: 10.1073/Pnas.1416674112 |
0.309 |
|
| 2015 |
da Silva SD, Morand GB, Alobaid FA, Hier MP, Mlynarek AM, Alaoui-Jamali MA, Kowalski LP. Epithelial-mesenchymal transition (EMT) markers have prognostic impact in multiple primary oral squamous cell carcinoma. Clinical & Experimental Metastasis. 32: 55-63. PMID 25433796 DOI: 10.1007/S10585-014-9690-1 |
0.337 |
|
| 2014 |
Xiao D, Chen S, Shao Q, Chen J, Bijian K, Laird DW, Alaoui-Jamali MA. Dynamin 2 interacts with connexin 26 to regulate its degradation and function in gap junction formation. The International Journal of Biochemistry & Cell Biology. 55: 288-97. PMID 25263585 DOI: 10.1016/J.Biocel.2014.09.021 |
0.318 |
|
| 2014 |
Xu B, Teng LH, Silva SD, Bijian K, Al Bashir S, Jie S, Dolph M, Alaoui-Jamali MA, Bismar TA. The significance of dynamin 2 expression for prostate cancer progression, prognostication, and therapeutic targeting. Cancer Medicine. 3: 14-24. PMID 24402972 DOI: 10.1002/Cam4.168 |
0.378 |
|
| 2014 |
da Silva SD, Alaoui-Jamali MA, Soares FA, Carraro DM, Brentani HP, Hier M, Rogatto SR, Kowalski LP. TWIST1 is a molecular marker for a poor prognosis in oral cancer and represents a potential therapeutic target. Cancer. 120: 352-62. PMID 24150986 DOI: 10.1002/Cncr.28404 |
0.317 |
|
| 2013 |
Bijian K, Lougheed C, Su J, Xu B, Yu H, Wu JH, Riccio K, Alaoui-Jamali MA. Targeting focal adhesion turnover in invasive breast cancer cells by the purine derivative reversine British Journal of Cancer. 109: 2810-2818. PMID 24169345 DOI: 10.1038/Bjc.2013.675 |
0.369 |
|
| 2013 |
Garcia AG, Nedev H, Bijian K, Su J, Alaoui-Jamali MA, Saragovi HU. Reduced in vivo lung metastasis of a breast cancer cell line after treatment with Herceptin mAb conjugated to chemotherapeutic drugs. Oncogene. 32: 2527-33. PMID 22797066 DOI: 10.1038/Onc.2012.283 |
0.334 |
|
| 2013 |
Silva SD, Alaoui-Jamali MA, Soares FA, Hier M, Rogatto SR, Kowalski LP. PP077 Oral Oncology. 49: S120. DOI: 10.1016/J.Oraloncology.2013.03.320 |
0.389 |
|
| 2013 |
Silva SD, Alobaid FA, Alaoui-Jamali M, Hier MP, Mlynarek A, Soares FA, Kowalski LP. PP022 Oral Oncology. 49: S101. DOI: 10.1016/J.Oraloncology.2013.03.265 |
0.319 |
|
| 2012 |
da Silva SD, Hier M, Mlynarek A, Kowalski LP, Alaoui-Jamali MA. Recurrent oral cancer: current and emerging therapeutic approaches. Frontiers in Pharmacology. 3: 149. PMID 23060791 DOI: 10.3389/Fphar.2012.00149 |
0.307 |
|
| 2012 |
Valentin MD, da Silva SD, Privat M, Alaoui-Jamali M, Bignon YJ. Molecular insights on basal-like breast cancer. Breast Cancer Research and Treatment. 134: 21-30. PMID 22234518 DOI: 10.1007/S10549-011-1934-Z |
0.32 |
|
| 2012 |
Bijian K, Zhang Z, Xu B, Jie S, Chen B, Wan S, Wu J, Jiang T, Alaoui-Jamali MA. Synthesis and biological activity of novel organoselenium derivatives targeting multiple kinases and capable of inhibiting cancer progression to metastases. European Journal of Medicinal Chemistry. 48: 143-52. PMID 22204902 DOI: 10.1016/J.Ejmech.2011.12.006 |
0.389 |
|
| 2011 |
Zhang P, Sun X, Xu B, Bijian K, Wan S, Li G, Alaoui-Jamali M, Jiang T. Total synthesis and bioactivity of the marine alkaloid pityriacitrin and some of its derivatives. European Journal of Medicinal Chemistry. 46: 6089-97. PMID 22047643 DOI: 10.1016/J.Ejmech.2011.10.036 |
0.339 |
|
| 2010 |
Xu Y, Bismar TA, Su J, Xu B, Kristiansen G, Varga Z, Teng L, Ingber DE, Mammoto A, Kumar R, Alaoui-Jamali MA. Filamin A regulates focal adhesion disassembly and suppresses breast cancer cell migration and invasion. The Journal of Experimental Medicine. 207: 2421-37. PMID 20937704 DOI: 10.1084/Jem.20100433 |
0.379 |
|
| 2009 |
Alaoui-Jamali MA, Gupta A, Szarek WA, Bismar TA, Gheorghe R, Schipper HM. A novel selective therapeutic targeting heme oxygenase-1 revealed a potent antimetastatic activity in androgen-refractory human prostate cancer models. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: e16090. PMID 27963085 DOI: 10.1200/Jco.2009.27.15_Suppl.E16090 |
0.38 |
|
| 2009 |
Alaoui-Jamali MA, Bismar TA, Gupta A, Szarek WA, Su J, Song W, Xu Y, Xu B, Liu G, Vlahakis JZ, Roman G, Jiao J, Schipper HM. A novel experimental heme oxygenase-1-targeted therapy for hormone-refractory prostate cancer. Cancer Research. 69: 8017-24. PMID 19808972 DOI: 10.1158/0008-5472.Can-09-0419 |
0.414 |
|
| 2009 |
Bijian K, Mlynarek AM, Balys RL, Jie S, Xu Y, Hier MP, Black MJ, Di Falco MR, LaBoissiere S, Alaoui-Jamali MA. Serum proteomic approach for the identification of serum biomarkers contributed by oral squamous cell carcinoma and host tissue microenvironment. Journal of Proteome Research. 8: 2173-85. PMID 19284786 DOI: 10.1021/Pr800979E |
0.361 |
|
| 2009 |
Poondra RR, Kumar NN, Bijian K, Prakesch M, Campagna-Slater V, Reayi A, Reddy PT, Choudhry A, Barnes ML, Leek DM, Daroszewska M, Lougheed C, Xu B, Schapira M, Alaoui-Jamali MA, et al. Discovery of indoline-based, natural-product-like compounds as probes of focal adhesion kinase signaling pathways. Journal of Combinatorial Chemistry. 11: 303-9. PMID 19146410 DOI: 10.1021/Cc8001525 |
0.304 |
|
| 2008 |
Behmoaram E, Bijian K, Jie S, Xu Y, Darnel A, Bismar TA, Alaoui-Jamali MA. Focal adhesion kinase-related proline-rich tyrosine kinase 2 and focal adhesion kinase are co-overexpressed in early-stage and invasive ErbB-2-positive breast cancer and cooperate for breast cancer cell tumorigenesis and invasiveness. The American Journal of Pathology. 173: 1540-50. PMID 18832579 DOI: 10.2353/Ajpath.2008.080292 |
0.378 |
|
| 2008 |
Behmoaram E, Bijian K, Bismar TA, Alaoui-Jamali MA. Early stage cancer cell invasion: signaling, biomarkers and therapeutic targeting. Frontiers in Bioscience : a Journal and Virtual Library. 13: 6314-25. PMID 18508662 DOI: 10.2741/3156 |
0.368 |
|
| 2007 |
Mlynarek AM, Balys RL, Su J, Hier MP, Black MJ, Alaoui-Jamali MA. A cell proteomic approach for the detection of secretable biomarkers of invasiveness in oral squamous cell carcinoma. Archives of Otolaryngology--Head & Neck Surgery. 133: 910-8. PMID 17875858 DOI: 10.1001/Archotol.133.9.910 |
0.401 |
|
| 2007 |
Li B, Lyle MP, Chen G, Li J, Hu K, Tang L, Alaoui-Jamali MA, Webster J. Substituted 6-amino-4H-[1,2]dithiolo[4,3-b]pyrrol-5-ones: synthesis, structure-activity relationships, and cytotoxic activity on selected human cancer cell lines. Bioorganic & Medicinal Chemistry. 15: 4601-8. PMID 17467996 DOI: 10.1016/J.Bmc.2007.04.017 |
0.337 |
|
| 2007 |
Darwish H, Cho JM, Loignon M, Alaoui-Jamali MA. Overexpression of SERTAD3, a putative oncogene located within the 19q13 amplicon, induces E2F activity and promotes tumor growth Oncogene. 26: 4319-4328. PMID 17260023 DOI: 10.1038/Sj.Onc.1210195 |
0.365 |
|
| 2006 |
Alaoui-Jamali MA. Protein tyrosine kinase signaling diversity and susceptibility to targeted kinase inhibitors Biomedicine and Pharmacotherapy. 60: 629-632. PMID 16949787 DOI: 10.1016/J.Biopha.2006.08.003 |
0.308 |
|
| 2006 |
Kalra J, Shao Q, Qin H, Thomas T, Alaoui-Jamali MA, Laird DW. Cx26 inhibits breast MDA-MB-435 cell tumorigenic properties by a gap junctional intercellular communication-independent mechanism. Carcinogenesis. 27: 2528-37. PMID 16777986 DOI: 10.1093/Carcin/Bgl110 |
0.42 |
|
| 2006 |
Hernandez M, Shao Q, Yang XJ, Luh SP, Kandouz M, Batist G, Laird DW, Alaoui-Jamali MA. A histone deacetylation-dependent mechanism for transcriptional repression of the gap junction gene cx43 in prostate cancer cells. The Prostate. 66: 1151-61. PMID 16652385 DOI: 10.1002/Pros.20451 |
0.33 |
|
| 2006 |
Alaoui-Jamali MA, Xu YJ. Proteomic technology for biomarker profiling in cancer: an update. Journal of Zhejiang University. Science. B. 7: 411-20. PMID 16625706 DOI: 10.1631/Jzus.2006.B0411 |
0.321 |
|
| 2006 |
Mlynarek AM, Balys R, Jie S, Xu Y, Hier MP, Black MJ, Alaoui-Jamali MA. A concerted cell and serum proteomic approach for the identification of oral squamous cell carcinoma biomarkers Journal of Clinical Oncology. 24: 5512-5512. DOI: 10.1200/Jco.2006.24.18_Suppl.5512 |
0.395 |
|
| 2006 |
Mlynarek AM, Balys RL, Hier MP, Black MJ, Alaoui-Jamali MA. S025 Biomarkers of Invasiveness in Oral Squamous Cell Carcinoma: A Cell Proteomic Approach Archives of Otolaryngology–Head & Neck Surgery. 132: 844. DOI: 10.1001/Archotol.132.8.844-A |
0.331 |
|
| 2005 |
Benlimame N, He Q, Jie S, Xiao D, Xu YJ, Loignon M, Schlaepfer DD, Alaoui-Jamali MA. FAK signaling is critical for ErbB-2/ErbB-3 receptor cooperation for oncogenic transformation and invasion. The Journal of Cell Biology. 171: 505-16. PMID 16275754 DOI: 10.1083/Jcb.200504124 |
0.369 |
|
| 2005 |
Brahimi F, Rachid Z, McNamee JP, Alaoui-Jamali MA, Tari AM, Jean-Claude BJ. Mechanism of action of a novel "combi-triazene" engineered to possess a polar functional group on the alkylating moiety: evidence for enhancement of potency. Biochemical Pharmacology. 70: 511-9. PMID 15982640 DOI: 10.1016/J.Bcp.2005.04.037 |
0.369 |
|
| 2005 |
Mamane Y, Loignon M, Palmer J, Hernandez E, Césaire R, Alaoui-Jamali M, Hiscott J. Repression of DNA repair mechanisms in IRF-4-expressing and HTLV-I-infected T lymphocytes. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 25: 43-51. PMID 15684621 DOI: 10.1089/Jir.2005.25.43 |
0.352 |
|
| 2004 |
Alaoui-Jamali MA, Dupré I, Qiang H. Prediction of drug sensitivity and drug resistance in cancer by transcriptional and proteomic profiling. Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy. 7: 245-55. PMID 15533762 DOI: 10.1016/J.Drup.2004.06.004 |
0.325 |
|
| 2004 |
Mathonnet G, Lachance S, Alaoui-Jamali M, Drobetsky EA. Expression of hepatitis B virus X oncoprotein inhibits transcription-coupled nucleotide excision repair in human cells. Mutation Research. 554: 305-18. PMID 15450428 DOI: 10.1016/J.Mrfmmm.2004.05.010 |
0.405 |
|
| 2004 |
Matheson SL, McNamee JP, Wang T, Alaoui-Jamali MA, Tari AM, Jean-Claude BJ. The combi-targeting concept: dissection of the binary mechanism of action of the combi-triazene SMA41 in vitro and antitumor activity in vivo. The Journal of Pharmacology and Experimental Therapeutics. 311: 1163-70. PMID 15358812 DOI: 10.1124/Jpet.104.071977 |
0.379 |
|
| 2004 |
Chow TY, Alaoui-Jamali MA, Yeh C, Yuen L, Griller D. The DNA double-stranded break repair protein endo-exonuclease as a therapeutic target for cancer. Molecular Cancer Therapeutics. 3: 911-9. PMID 15299074 |
0.336 |
|
| 2004 |
Kandouz M, Bier A, Carystinos GD, Alaoui-Jamali MA, Batist G. Connexin43 pseudogene is expressed in tumor cells and inhibits growth. Oncogene. 23: 4763-70. PMID 15122329 DOI: 10.1038/Sj.Onc.1207506 |
0.435 |
|
| 2004 |
Al Moustafa AE, Foulkes WD, Benlimame N, Wong A, Yen L, Bergeron J, Batist G, Alpert L, Alaoui-Jamali MA. E6/E7 proteins of HPV type 16 and ErbB-2 cooperate to induce neoplastic transformation of primary normal oral epithelial cells. Oncogene. 23: 350-8. PMID 14724563 DOI: 10.1038/Sj.Onc.1207148 |
0.318 |
|
| 2003 |
Qin H, Shao Q, Thomas T, Kalra J, Alaoui-Jamali MA, Laird DW. Connexin26 regulates the expression of angiogenesis-related genes in human breast tumor cells by both GJIC-dependent and -independent mechanisms. Cell Communication & Adhesion. 10: 387-93. PMID 14681046 DOI: 10.1080/Cac.10.4-6.387.393 |
0.392 |
|
| 2003 |
Qin H, Shao Q, Igdoura SA, Alaoui-Jamali MA, Laird DW. Lysosomal and proteasomal degradation play distinct roles in the life cycle of Cx43 in gap junctional intercellular communication-deficient and -competent breast tumor cells. The Journal of Biological Chemistry. 278: 30005-14. PMID 12767974 DOI: 10.1074/Jbc.M300614200 |
0.378 |
|
| 2003 |
Alaoui-Jamali MA, Qiang H. The interface between ErbB and non-ErbB receptors in tumor invasion: clinical implications and opportunities for target discovery. Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy. 6: 95-107. PMID 12729807 DOI: 10.1016/S1368-7646(03)00024-4 |
0.337 |
|
| 2003 |
Carystinos GD, Kandouz M, Alaoui-Jamali MA, Batist G. Unexpected induction of the human connexin 43 promoter by the ras signaling pathway is mediated by a novel putative promoter sequence. Molecular Pharmacology. 63: 821-31. PMID 12644583 DOI: 10.1124/Mol.63.4.821 |
0.344 |
|
| 2002 |
Yen L, Benlimame N, Nie ZR, Xiao D, Wang T, Al Moustafa AE, Esumi H, Milanini J, Hynes NE, Pages G, Alaoui-Jamali MA. Differential regulation of tumor angiogenesis by distinct ErbB homo- and heterodimers. Molecular Biology of the Cell. 13: 4029-44. PMID 12429844 DOI: 10.1091/Mbc.E02-02-0084 |
0.336 |
|
| 2002 |
Al Moustafa AE, Yen L, Benlimame N, Alaoui-Jamali MA. Regulation of E-cadherin/catenin complex patterns by epidermal growth factor receptor modulation in human lung cancer cells. Lung Cancer (Amsterdam, Netherlands). 37: 49-56. PMID 12057867 DOI: 10.1016/S0169-5002(02)00025-9 |
0.361 |
|
| 2002 |
Xu Z, Chen ZP, Malapetsa A, Alaoui-Jamali M, Bergeron J, Monks A, Myers TG, Mohr G, Sausville EA, Scudiero DA, Aloyz R, Panasci LC. DNA repair protein levels vis-à-vis anticancer drug resistance in the human tumor cell lines of the National Cancer Institute drug screening program. Anti-Cancer Drugs. 13: 511-9. PMID 12045463 DOI: 10.1097/00001813-200206000-00010 |
0.419 |
|
| 2002 |
Qin H, Shao Q, Curtis H, Galipeau J, Belliveau DJ, Wang T, Alaoui-Jamali MA, Laird DW. Retroviral delivery of connexin genes to human breast tumor cells inhibits in vivo tumor growth by a mechanism that is independent of significant gap junctional intercellular communication. The Journal of Biological Chemistry. 277: 29132-8. PMID 12042301 DOI: 10.1074/Jbc.M200797200 |
0.376 |
|
| 2002 |
Barsalou A, Dayan G, Anghel SI, Alaoui-Jamali M, Van de Velde P, Mader S. Growth-stimulatory and transcriptional activation properties of raloxifene in human endometrial Ishikawa cells. Molecular and Cellular Endocrinology. 190: 65-73. PMID 11997179 DOI: 10.1016/S0303-7207(02)00011-4 |
0.361 |
|
| 2002 |
Al Moustafa AE, Alaoui-Jamali MA, Batist G, Hernandez-Perez M, Serruya C, Alpert L, Black MJ, Sladek R, Foulkes WD. Identification of genes associated with head and neck carcinogenesis by cDNA microarray comparison between matched primary normal epithelial and squamous carcinoma cells. Oncogene. 21: 2634-40. PMID 11965536 DOI: 10.1038/Sj.Onc.1205351 |
0.39 |
|
| 2001 |
Huynh H, Alpert L, Alaoui-Jamali MA, Ng CY, Chan TWM. Co-administration of finasteride and the pure anti-oestrogen ICI 182,780 act synergistically in modulating the IGF system in rat prostate Journal of Endocrinology. 171: 109-118. PMID 11572795 DOI: 10.1677/Joe.0.1710109 |
0.324 |
|
| 2001 |
Trudeau C, Yuan S, Galipeau J, Benlimame N, Alaoui-Jamali MA, Batist G. A novel parasite-derived suicide gene for cancer gene therapy with specificity for lung cancer cells Human Gene Therapy. 12: 1673-1680. PMID 11535170 DOI: 10.1089/10430340152528165 |
0.388 |
|
| 2001 |
Marcantonio D, Chalifour LE, Alaoui-Jamali And H T Huynh MA, Alaoui-Jamali MA, Alaoui-Jamali MA, Huynh HT, Huynh HT. Steroid-sensitive gene-1 is an androgen-regulated gene expressed in prostatic smooth muscle cells in vivo. Journal of Molecular Endocrinology. 26: 175-84. PMID 11357054 DOI: 10.1677/Jme.0.0260175 |
0.684 |
|
| 2001 |
Marcantonio D, Chalifour LE, Alaoui-Jamali MA, Alpert L, Huynh HT. Cloning and characterization of a novel gene that is regulated by estrogen and is associated with mammary gland carcinogenesis. Endocrinology. 142: 2409-18. PMID 11356689 DOI: 10.1210/Endo.142.6.8154 |
0.699 |
|
| 2001 |
Prudencio J, Akutsu N, Benlimame N, Wang T, Bastien Y, Lin R, Black MJ, Alaoui-Jamali MA, White JH. Action of low calcemic 1α,25-dihydroxyvitamin D3 analogue EB1089 in head and neck squamous cell carcinoma Journal of the National Cancer Institute. 93: 745-753. PMID 11353784 DOI: 10.1093/Jnci/93.10.745 |
0.374 |
|
| 2001 |
Jaitovich-Groisman I, Benlimame N, Slagle BL, Perez MH, Alpert L, Song DJ, Fotouhi-Ardakani N, Galipeau J, Alaoui-Jamali MA. Transcriptional Regulation of the TFIIH Transcription Repair Components XPB and XPD by the Hepatitis B Virus x Protein in Liver Cells and Transgenic Liver Tissue Journal of Biological Chemistry. 276: 14124-14132. PMID 11278765 DOI: 10.1074/Jbc.M010852200 |
0.4 |
|
| 2001 |
Carystinos GD, Alaoui-Jamali MA, Phipps J, Yen L, Batist G. Upregulation of gap junctional intercellular communication and connexin 43 expression by cyclic-AMP and all-trans-retinoic acid is associated with glutathione depletion and chemosensitivity in neuroblastoma cells Cancer Chemotherapy and Pharmacology. 47: 126-132. PMID 11269738 DOI: 10.1007/S002800000231 |
0.362 |
|
| 2001 |
Caruso JA, Reiners JJ, Emond J, Shultz T, Tainsky MA, Alaoui-Jamali M, Batist G. Genetic alteration of chromosome 8 is a common feature of human mammary epithelial cell lines transformed in vitro with benzo[a]pyrene. Mutation Research. 473: 85-99. PMID 11166028 DOI: 10.1016/S0027-5107(00)00140-8 |
0.34 |
|
| 2000 |
Cho JM, Song DJ, Bergeron J, Benlimame N, Wold MS, Alaoui-Jamali MA. RBT1, a novel transcriptional co-activator, binds the second subunit of replication protein A. Nucleic Acids Research. 28: 3478-85. PMID 10982866 DOI: 10.1093/Nar/28.18.3478 |
0.426 |
|
| 2000 |
Jaitovitch-Groisman I, Fotouhi-Ardakani N, Schecter RL, Woo A, Alaoui-Jamali MA, Batist G. Modulation of glutathione S-transferase alpha by hepatitis B virus and the chemopreventive drug oltipraz Journal of Biological Chemistry. 275: 33395-33403. PMID 10934196 DOI: 10.1074/Jbc.M003754200 |
0.369 |
|
| 2000 |
Yen L, You XL, Al Moustafa AE, Batist G, Hynes NE, Mader S, Meloche S, Alaoui-Jamali MA. Heregulin selectively upregulates vascular endothelial growth factor secretion in cancer cells and stimulates angiogenesis Oncogene. 19: 3460-3469. PMID 10918604 DOI: 10.1038/Sj.Onc.1203685 |
0.375 |
|
| 2000 |
Sohn S, Jaitovitch-Groisman I, Benlimame N, Galipeau J, Batist G, Alaoui-Jamali MA. Retroviral expression of the hepatitis B virus x gene promotes liver cell susceptibility to carcinogen-induced site specific mutagenesis Mutation Research - Dna Repair. 460: 17-28. PMID 10856831 DOI: 10.1016/S0921-8777(00)00010-0 |
0.392 |
|
| 1999 |
Horton JK, Roy G, Piper JT, Van Houten B, Awasthi YC, Mitra S, Alaoui-Jamali MA, Boldogh I, Singhal SS. Characterization of a chlorambucil-resistant human ovarian carcinoma cell line overexpressing glutathione S-transferase μ Biochemical Pharmacology. 58: 693-702. PMID 10413308 DOI: 10.1016/S0006-2952(99)00142-2 |
0.341 |
|
| 1999 |
Groisman IJ, Koshy R, Henkler F, Groopman JD, Alaoui-Jamali MA. Downregulation of DNA excision repair by the hepatitis B virus-x protein occurs in p53-proficient and p53-deficient cells. Carcinogenesis. 20: 479-83. PMID 10190565 DOI: 10.1093/Carcin/20.3.479 |
0.708 |
|
| 1998 |
Arya P, Alibhai N, Qin H, Burton GW, Batist G, You SXL, Alaoui-Jamali MA. Design and synthesis of analogs of vitamin E: Antiproliferative activity against human breast adenocarcinoma cells Bioorganic and Medicinal Chemistry Letters. 8: 2433-2438. PMID 9873556 DOI: 10.1016/S0960-894X(98)00438-7 |
0.313 |
|
| 1998 |
You XL, Yen L, Zeng-Rong N, Al Moustafa AE, Alaoui-Jamali MA. Dual effect of erbB-2 depletion on the regulation of DNA repair and cell cycle mechanisms in non-small cell lung cancer cells Oncogene. 17: 3177-3186. PMID 9872333 DOI: 10.1038/Sj.Onc.1202246 |
0.451 |
|
| 1998 |
Paterson J, Uriel C, Egron MJ, Herscovici J, Antonakis K, Alaoui-Jamali MA. Antiproliferative and apoptotic activities of ketonucleosides and keto- C-glycosides against non-small-cell lung cancer cells with intrinsic drug resistance Antimicrobial Agents and Chemotherapy. 42: 779-784. PMID 9559782 DOI: 10.1128/Aac.42.4.779 |
0.384 |
|
| 1998 |
Christodoulopoulos G, Fotouhi N, Krajewski S, Reed JC, Alaoui-Jamali M, Panasci L. Relationship between nitrogen mustard drug resistance in B-cell chronic lymphocytic leukemia (B-CLL) and protein expression of Bcl-2, Bax, Bcl-X and p53. Cancer Letters. 121: 59-67. PMID 9459175 DOI: 10.1016/S0304-3835(97)00336-4 |
0.315 |
|
| 1997 |
Alaoui-Jamali MA, Paterson J, Al Moustafa AE, Yen L. The role of ErbB-2 tyrosine kinase receptor in cellular intrinsic chemoresistance: Mechanisms and implications Biochemistry and Cell Biology. 75: 315-325. PMID 9493954 DOI: 10.1139/O97-060 |
0.42 |
|
| 1997 |
Yen L, Zeng-Rong N, You XL, Richard S, Langton-Webster BC, Alaoui-Jamali MA. Regulation of cellular response to cisplatin-induced DNA damage and DNA repair in cells overexpressing p185(erbB-2) is dependent on the ras signaling pathway Oncogene. 14: 1827-1835. PMID 9150389 DOI: 10.1038/Sj.Onc.1201019 |
0.384 |
|
| 1995 |
Yen L, Woo A, Christopoulopoulos G, Batist G, Panasci L, Roy R, Mitra S, Alaoui-Jamali MA. Enhanced host cell reactivation capacity and expression of DNA repair genes in human breast cancer cells resistant to bi-functional alkylating agents Mutation Research-Dna Repair. 337: 179-189. PMID 7491121 DOI: 10.1016/0921-8777(95)00022-C |
0.441 |
|
| 1994 |
Alaoui-Jamali M, Loubaba BB, Robyn S, Tapiero H, Batist G. Effect of DNA-repair-enzyme modulators on cytotoxicity of L-phenylalanine mustard and cis-diamminedichloroplatinum (II) in mammary carcinoma cells resistant to alkylating drugs. Cancer Chemotherapy and Pharmacology. 34: 153-8. PMID 8194166 DOI: 10.1007/Bf00685933 |
0.359 |
|
| 1994 |
C.-Gaudreault R, Alaoui-Jamali MA, Batist G, Béchard P, Lacroix J, Poyet P. Lack of cross-resistance to a new cytotoxic arylchloroethyl urea in various drug-resistant tumor cells Cancer Chemotherapy and Pharmacology. 33: 489-492. PMID 8137459 DOI: 10.1007/Bf00686506 |
0.349 |
|
| 1993 |
Schecter RL, Alaoui-Jamali MA, Woo A, Fahl WE, Batist G. Expression of a rat glutathione-S-transferase complementary DNA in rat mammary carcinoma cells: impact upon alkylator-induced toxicity. Cancer Research. 53: 4900-6. PMID 8402679 |
0.335 |
|
| 1992 |
Alaoui-Jamali MA, Batist G, Lehnert S. Radiation-induced damage to DNA in drug- and radiation-resistant sublines of a human breast cancer cell line Radiation Research. 129: 37-42. PMID 1728055 DOI: 10.2307/3577900 |
0.354 |
|
| 1992 |
Alaoui-Jamali MA, Panasci L, Centurioni GM, Schecter R, Lehnert S, Batist G. Nitrogen mustard-DNA interaction in melphalan-resistant mammary carcinoma cells with elevated intracellular glutathione and glutathione-S-transferase activity Cancer Chemotherapy and Pharmacology. 30: 341-347. PMID 1505071 DOI: 10.1007/Bf00689960 |
0.402 |
|
| 1992 |
Schecter RL, Alaoui-Jamali MA, Batist G. Glutathione S-transferase in chemotherapy resistance and in carcinogenesis Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire. 70: 349-353. PMID 1353967 DOI: 10.1139/O92-054 |
0.334 |
|
| 1987 |
Alaoui-Jamali MA, Egron MJ, Bessodes M, Antonakis K, Chouroulinkov I. Relationship between the structure and cytotoxic activity of new unsaturated ketonucleosides tested on eight cell lines European Journal of Medicinal Chemistry. 22: 305-310. DOI: 10.1016/0223-5234(87)90267-4 |
0.324 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2002 |
Dupont E, Falardeau P, Mousa SA, Dimitriadou V, Pepin MC, Wang T, Alaoui-Jamali MA. Antiangiogenic and antimetastatic properties of Neovastat (AE-941), an orally active extract derived from cartilage tissue. Clinical & Experimental Metastasis. 19: 145-53. PMID 11964078 DOI: 10.1023/A:1014546909573 |
0.3 |
|
| 1988 |
Alaoui-Jamali MA, Castonguay A, Schuller HM. In vitro genotoxicity of 4(methylnitrosamine)-1-(3-pyridyl) 1-butanone activated by hamster maternal and fetal tissues Carcinogenesis. 9: 2319-2324. PMID 3191579 DOI: 10.1093/Carcin/9.12.2319 |
0.296 |
|
| 2021 |
da Silva SD, Marchi FA, Su J, Yang L, Valverde L, Hier J, Bijian K, Hier M, Mlynarek A, Kowalski LP, Alaoui-Jamali MA. Co-Overexpression of TWIST1-CSF1 Is a Common Event in Metastatic Oral Cancer and Drives Biologically Aggressive Phenotype. Cancers. 13. PMID 33466385 DOI: 10.3390/cancers13010153 |
0.295 |
|
| 2004 |
Al Moustafa AE, Foulkes WD, Wong A, Jallal H, Batist G, Yu Q, Herlyn M, Sicinski P, Alaoui-Jamali MA. Cyclin D1 is essential for neoplastic transformation induced by both E6/E7 and E6/E7/ErbB-2 cooperation in normal cells. Oncogene. 23: 5252-6. PMID 15229656 DOI: 10.1038/Sj.Onc.1207679 |
0.294 |
|
| 2022 |
Yu HG, Bijian K, da Silva SD, Su J, Morand G, Spatz A, Alaoui-Jamali MA. NEDD9 links anaplastic thyroid cancer stemness to chromosomal instability through integrated centrosome asymmetry and DNA sensing regulation. Oncogene. PMID 35449243 DOI: 10.1038/s41388-022-02317-7 |
0.293 |
|
| 2002 |
Aloyz R, Xu ZY, Bello V, Bergeron J, Han FY, Yan Y, Malapetsa A, Alaoui-Jamali MA, Duncan AM, Panasci L. Regulation of cisplatin resistance and homologous recombinational repair by the TFIIH subunit XPD. Cancer Research. 62: 5457-62. PMID 12359753 |
0.291 |
|
| 2014 |
Silva SD, Alaoui-Jamali MA, Hier M, Soares FA, Graner E, Kowalski LP. Cooverexpression of ERBB1 and ERBB4 receptors predicts poor clinical outcome in pN+ oral squamous cell carcinoma with extranodal spread. Clinical & Experimental Metastasis. 31: 307-16. PMID 24338375 DOI: 10.1007/S10585-013-9629-Y |
0.29 |
|
| 1995 |
Zeng-Rong N, Paterson J, Alpert L, Alaoui-Jamali MA, Tsao MS, Viallet J. Elevated DNA Repair Capacity Is Associated with Intrinsic Resistance of Lung Cancer to Chemotherapy Cancer Research. 55: 4760-4764. PMID 7585500 |
0.29 |
|
| 2008 |
Prakesch M, Bijian K, Campagna-Slater V, Quevillon S, Joseph R, Wei CQ, Sesmilo E, Reayi A, Poondra RR, Barnes ML, Leek DM, Xu B, Lougheed C, Schapira M, Alaoui-Jamali M, et al. Building skeletally diverse architectures on the Indoline Scaffold: the discovery of a chemical probe of focal adhesion kinase signaling networks. Bioorganic & Medicinal Chemistry. 16: 9596-602. PMID 18835181 DOI: 10.1016/J.Bmc.2008.09.025 |
0.289 |
|
| 2001 |
Gilmore J, Rotondo F, Pelletier AM, LaMarre J, Alaoui-Jamali M, Kirby GM. Identification of a 43-kDa protein in human liver cytosol that binds to the 3′-untranslated region of CYP2A6 mRNA Biochemical Pharmacology. 62: 669-678. PMID 11551511 DOI: 10.1016/S0006-2952(01)00720-1 |
0.288 |
|
| 1995 |
Bramson J, McQuillan A, Aubin R, Alaoui-Jamali M, Batist G, Christodoulopoulos G, Panasci LC. Nitrogen mustard drug resistant B-cell chronic lymphocytic leukemia as an in vivo model for crosslinking agent resistance. Mutation Research. 336: 269-78. PMID 7739615 DOI: 10.1016/0921-8777(94)00063-C |
0.288 |
|
| 2023 |
de Lima JM, Macedo CCS, Barbosa GV, Castellano LRC, Hier MP, Alaoui-Jamali MA, da Silva SD. E-liquid alters oral epithelial cell function to promote epithelial to mesenchymal transition and invasiveness in preclinical oral squamous cell carcinoma. Scientific Reports. 13: 3330. PMID 36849550 DOI: 10.1038/s41598-023-30016-0 |
0.287 |
|
| 2021 |
de Lima JM, Castellano LRC, Bonan PRF, de Medeiros ES, Hier M, Bijian K, Alaoui-Jamali MA, Da Cruz Perez DE, da Silva SD. Chitosan/PCL nanoparticles can improve anti-neoplastic activity of 5-fluorouracil in head and neck cancer Through autophagy activation. The International Journal of Biochemistry & Cell Biology. 105964. PMID 33667680 DOI: 10.1016/j.biocel.2021.105964 |
0.285 |
|
| 2001 |
Huynh HT, Alpert L, Laird DW, Batist G, Chalifour L, Alaoui-Jamali MA. Regulation of the gap junction connexin 43 gene by androgens in the prostate. Journal of Molecular Endocrinology. 26: 1-10. PMID 11174849 DOI: 10.1677/Jme.0.0260001 |
0.285 |
|
| 2003 |
Scrivens PJ, Alaoui-Jamali MA, Giannini G, Wang T, Loignon M, Batist G, Sandor VA. Cdc25A-inhibitory properties and antineoplastic activity of bisperoxovanadium analogues. Molecular Cancer Therapeutics. 2: 1053-9. PMID 14578470 |
0.285 |
|
| 2009 |
Xu Y, Benlimame N, Su J, He Q, Alaoui-Jamali MA. Regulation of focal adhesion turnover by ErbB signalling in invasive breast cancer cells British Journal of Cancer. 100: 633-643. PMID 19190626 DOI: 10.1038/sj.bjc.6604901 |
0.284 |
|
| 2000 |
Bergeron J, Benlimame N, Zeng-Rong N, Xiao D, Scrivens PJ, Koromilas AE, Alaoui-Jamali MA. Identification of the interferon-inducible double-stranded RNA-dependent protein kinase as a regulator of cellular response to bulky adducts Cancer Research. 60: 6800-6804. PMID 11156368 |
0.284 |
|
| 2016 |
Saad A, Bijian K, Qiu D, da Silva SD, Marques M, Chang CH, Nassour H, Ramotar D, Damaraju S, Mackey J, Bismar T, Witcher M, Alaoui-Jamali MA. Insights into a novel nuclear function for Fascin in the regulation of the amino-acid transporter SLC3A2. Scientific Reports. 6: 36699. PMID 27819326 DOI: 10.1038/Srep36699 |
0.283 |
|
| 2017 |
Kahouli I, Malhotra M, Westfall S, Alaoui-Jamali M, Prakash S. Abstract 254: The potential ofLactobacillusprobiotic treatments in colorectal cancer (CRC) Cancer Research. 77: 254-254. DOI: 10.1158/1538-7445.Am2017-254 |
0.281 |
|
| 1996 |
Kirby GM, Batist G, Alpert L, Lamoureux E, Cameron RG, Alaoui-Jamali MA. Overexpression of cytochrome P-450 isoforms involved in aflatoxin B1 bioactivation in human liver with cirrhosis and hepatitis Toxicologic Pathology. 24: 458-467. PMID 8864187 DOI: 10.1177/019262339602400408 |
0.28 |
|
| 2008 |
Alaoui-Jamali M. Early Stage Breast Cancer Invasion Signalling: A Network of Novel Clinical Biomarkers and Therapeutic Targets Biomedicine & Pharmacotherapy. 62: 425. DOI: 10.1016/J.Biopha.2008.06.015 |
0.276 |
|
| 1996 |
Kirby GM, Batist G, Fotouhi-Ardakani N, Nakazawa H, Yamasaki H, Kew M, Cameron RG, Alaoui-Jamali MA. Allele-specific PCR analysis of p53 codon 249 AGT transversion in liver tissues from patients with viral hepatitis International Journal of Cancer. 68: 21-25. PMID 8895534 DOI: 10.1002/(Sici)1097-0215(19960927)68:1<21::Aid-Ijc4>3.0.Co;2-Z |
0.274 |
|
| 2007 |
Hamilton D, Loignon M, Alaoui-Jamali MA, Batist G. Novel use of the fluorescent dye 5-(and-6)-chloromethyl SNARF-1 acetate for the measurement of intracellular glutathione in leukemic cells and primary lymphocytes. Cytometry. Part a : the Journal of the International Society For Analytical Cytology. 71: 709-15. PMID 17623874 DOI: 10.1002/Cyto.A.20433 |
0.272 |
|
| 2014 |
Gupta A, Lacoste B, Pistell PJ, Pistel PJ, Ingram DK, Hamel E, Alaoui-Jamali MA, Szarek WA, Vlahakis JZ, Jie S, Song W, Schipper HM. Neurotherapeutic effects of novel HO-1 inhibitors in vitro and in a transgenic mouse model of Alzheimer's disease. Journal of Neurochemistry. 131: 778-90. PMID 25111043 DOI: 10.1111/Jnc.12927 |
0.271 |
|
| 2017 |
Lubov J, Maschietto M, Ibrahim I, Mlynarek A, Hier M, Kowalski LP, Alaoui-Jamali MA, da Silva SD. Meta-analysis of microRNAs expression in head and neck cancer: uncovering association with outcome and mechanisms. Oncotarget. 8: 55511-55524. PMID 28903437 DOI: 10.18632/Oncotarget.19224 |
0.271 |
|
| 2015 |
Alaoui-Jamali MA, Cao YH, Bijian K, Alkailani MI. Tumor-derived exosomes in metastasis signaling and implications Intercellular Communication in Cancer. 189-200. DOI: 10.1007/978-94-017-7380-5_7 |
0.264 |
|
| 2013 |
Jin H, Zhang P, Bijian K, Ren S, Wan S, Alaoui-Jamali MA, Jiang T. Total synthesis and biological activity of marine alkaloid Eudistomins Y1-Y7 and their analogues. Marine Drugs. 11: 1427-39. PMID 23629726 DOI: 10.3390/Md11051427 |
0.264 |
|
| 1999 |
Laird DW, Fistouris P, Batist G, Alpert L, Huynh HT, Carystinos GD, Alaoui-Jamali MA. Deficiency of connexin43 gap junctions is an independent marker for breast tumors. Cancer Research. 59: 4104-10. PMID 10463615 |
0.263 |
|
| 1991 |
Alaoui-Jamali MA, Rossignol G, Castonguay A. Protective effects of vitamin A against the genotoxicity of NNK, a nicotine-derived N-nitrosamine Carcinogenesis. 12: 379-384. PMID 2009584 DOI: 10.1093/Carcin/12.3.379 |
0.263 |
|
| 1997 |
Groisman IJ, Koshy R, Batist G, Ardakani NF, Zeng-Rong R, Yen L, You XL, Alaoui-Jamali MA. Transcriptional repression of TFIIH subunits XPB/ERCC3 and XPD/ERCC2 by hepatitis B virus X protein Biochemistry and Cell Biology. 75: 469. DOI: 10.1139/Abstract14 |
0.261 |
|
| 2014 |
Morand GB, da Silva SD, Hier MP, Alaoui-Jamali MA. Insights into genetic and epigenetic determinants with impact on vitamin d signaling and cancer association studies: the case of thyroid cancer. Frontiers in Oncology. 4: 309. PMID 25414832 DOI: 10.3389/Fonc.2014.00309 |
0.259 |
|
| 2003 |
Hamilton D, Wu JH, Alaoui-Jamali M, Batist G. A novel missense mutation in the gamma-glutamylcysteine synthetase catalytic subunit gene causes both decreased enzymatic activity and glutathione production. Blood. 102: 725-30. PMID 12663448 DOI: 10.1182/Blood-2002-11-3622 |
0.255 |
|
| 2022 |
da Silva SD, Morand GB, Diesel L, de Lima JM, Bijian K, Kailasam S, Lefebvre F, Bourque G, Hier M, Alaoui-Jamali MA. Identification of R-Spondin Gene Signature Predictive of Metastatic Progression in BRAFV-Positive Papillary Thyroid Cancer. Cells. 12. PMID 36611933 DOI: 10.3390/cells12010139 |
0.252 |
|
| 2011 |
Alaoui-Jamali MA, Bijian K, Batist G. Emerging drug discovery approaches for selective targeting of "precursor" metastatic breast cancer cells: Highlights and perspectives American Journal of Translational Research. 3: 434-444. |
0.246 |
|
| 1993 |
Alaoui-Jamali MA, Schecter RL, Rustum YM, Centurioni MG, Lehnert S, Batist G. In vivo reversal of doxorubicin resistance by a new tiapamil analog Ro11- 2933 Journal of Pharmacology and Experimental Therapeutics. 264: 1299-1304. PMID 8450465 |
0.245 |
|
| 2003 |
Panasci L, Stinson SF, Melnychuk D, Sandor V, Miller WH, Batist G, Patenaude F, Bangash N, Panarello L, Alaoui-Jamali M, Sausville E. SarCNU, a nitrosourea analog on a day 1, 5, and 9 oral schedule: a phase I and pharmacokinetic study in patients with advanced solid tumors. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 21: 232-40. PMID 12525514 DOI: 10.1200/Jco.2003.03.047 |
0.244 |
|
| 2004 |
Aloyz R, Grzywacz K, Xu ZY, Loignon M, Alaoui-Jamali MA, Panasci L. Imatinib sensitizes CLL lymphocytes to chlorambucil Leukemia. 18: 409-414. PMID 14712290 DOI: 10.1038/sj.leu.2403247 |
0.242 |
|
| 1986 |
Alaoui-jamali MA, Lasne CL, Antonakis K, Chouroulinkov I. Absence of genotoxic effects in cells exposed to four ketonucleoside derivatives Mutagenesis. 1: 411-417. PMID 3331679 DOI: 10.1093/mutage/1.6.411 |
0.241 |
|
| 1999 |
Moustafa AEA, Yansouni C, Alaoui-Jamali MA, O'Connor-McCourt M. Up-regulation of E-cadherin by an anti-epidermal growth factor receptor monoclonal antibody in lung cancer cell lines Clinical Cancer Research. 5: 681-686. PMID 10100722 |
0.239 |
|
| 1987 |
Alaoui-Jamali MA, Tapiero H, Antonakis K, Chouroulinkov I. Cytotoxic potential of ketonucleosides Anticancer Research. 7: 501-504. PMID 3477123 |
0.22 |
|
| 2001 |
Zhang J, Sauriol F, Mamer O, You XL, Alaoui-Jamali MA, Batist G, Zamir LO. New taxane analogues from the needles of Taxus canadensis Journal of Natural Products. 64: 450-455. PMID 11325226 DOI: 10.1021/Np0004449 |
0.211 |
|
| 2023 |
Krishnan R, Lapierre M, Gautreau B, Nixon KCJ, El Ghamrasni S, Patel PS, Hao J, Yerlici VT, Guturi KKN, St-Germain J, Mateo F, Saad A, Algouneh A, Earnshaw R, Shili D, ... ... Alaoui-Jamali M, et al. RNF8 ubiquitylation of XRN2 facilitates R-loop resolution and restrains genomic instability in BRCA1 mutant cells. Nucleic Acids Research. PMID 37697435 DOI: 10.1093/nar/gkad733 |
0.211 |
|
| 1990 |
Alaoui-Jamali MA, Gagnon R, El Alami N, Castonguay A. Cytotoxicity, sister-chromatid exchanges and DNA single-strand breaks induced by 4-oxo-4-(3-pyridyl)butanal, a metabolite of a tobacco-specific N-nitrosamine Mutation Research/Genetic Toxicology. 240: 25-33. PMID 2294414 DOI: 10.1016/0165-1218(90)90005-M |
0.208 |
|
| 1999 |
Carystinos GD, Katabi MM, Laird DW, Galipeau J, Chan H, Alaoui-Jamali MA, Batist G. Cyclic-AMP induction of gap junctional intercellular communication increases bystander effect in suicide gene therapy Clinical Cancer Research. 5: 61-68. PMID 9918203 |
0.205 |
|
| 2004 |
Alaoui-Jamali M, Qiang H, Benlimame N, Dupre I. 145 A mitogenic-independent mechanism for ErbB receptor-induced tumour cell invasion European Journal of Cancer Supplements. 2: 46-47. DOI: 10.1016/S1359-6349(04)80153-8 |
0.202 |
|
| 1996 |
Alaoui-Jamali M, Sankar Mitra S. Les mécanismes de réparation de l'ADN : des cibles potentielles en pharmacologie du cancer. MéDecine/Sciences. 12: 766. DOI: 10.4267/10608/817 |
0.194 |
|
| 2021 |
Hier J, Vachon O, Bernstein A, Ibrahim I, Mlynarek A, Hier M, Alaoui-Jamali MA, Maschietto M, da Silva SD. Portrait of DNA methylated genes predictive of poor prognosis in head and neck cancer and the implication for targeted therapy. Scientific Reports. 11: 10012. PMID 33976322 DOI: 10.1038/s41598-021-89476-x |
0.192 |
|
| 2009 |
Darnel AD, Behmoaram E, Vollmer RT, Corcos J, Bijian K, Sircar K, Su J, Jiao J, Alaoui-Jamali MA, Bismar TA. Fascin regulates prostate cancer cell invasion and is associated with metastasis and biochemical failure in prostate cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 1376-83. PMID 19228738 DOI: 10.1158/1078-0432.CCR-08-1789 |
0.181 |
|
| 1991 |
Alaoui-Jamali MA, Bélanger PM, Rossignol G, Castonguay A. Metabolism, sister chromatid exchanges, and DNA single-strand breaks induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and their modulation by vitamin A in vitro Cancer Research. 51: 3946-3950. PMID 1855212 |
0.18 |
|
| 2022 |
Bijian K, Wernic D, Nivedha AK, Su J, Lim FPL, Miron CE, Amzil H, Moitessier N, Alaoui-Jamali MA. Novel Aurora A and Protein Kinase C (α, β1, β2, and θ) Multitarget Inhibitors: Impact of Selenium Atoms on the Potency and Selectivity. Journal of Medicinal Chemistry. PMID 35167283 DOI: 10.1021/acs.jmedchem.1c01031 |
0.175 |
|
| 2023 |
Yi Q, Liu W, Seo JH, Su J, Alaoui-Jamali MA, Luo J, Lin R, Wu JH. Discovery of a Small-Molecule Inhibitor Targeting the Androgen Receptor N-Terminal Domain for Castration-Resistant Prostate Cancer. Molecular Cancer Therapeutics. 22: 570-582. PMID 37139712 DOI: 10.1158/1535-7163.MCT-22-0237 |
0.174 |
|
| 1990 |
Alaoui-Jamali MA, Massey TE, Douglas A, Rossignol G, Castonguay A. In vitro metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by lung cells isolated from Syrian golden hamster Cancer Letters. 52: 49-55. PMID 2354419 DOI: 10.1016/0304-3835(90)90076-A |
0.172 |
|
| 2006 |
Luh SP, Alaoui-Jamali MA. New targets, new agents, and the evolving phenomena of drug resistance in cancer Current Cancer Therapy Reviews. 2: 23-30. DOI: 10.2174/157339406775471821 |
0.168 |
|
| 2006 |
Balys R, Alaoui-Jamali M, Hier M, Black M, Domanowski G, Rochon L, Jie S. Clinically relevant oral cancer model for serum proteomic eavesdropping on the tumour microenvironment Journal of Otolaryngology. 35: 157-166. PMID 16929991 DOI: 10.2310/7070.2005.0032 |
0.16 |
|
| 2003 |
Alaoui-Jamali MA, Song DJ, Benlimame N, Yen L, Deng X, Hernandez-Perez M, Wang T. Regulation of multiple tumor microenvironment markers by overexpression of single or paired combinations of ErbB receptors. Cancer Research. 63: 3764-74. PMID 12839972 |
0.148 |
|
| 1990 |
Liu L, Alaoui-Jamali MA, El Alami N, Castonguay A. Metabolism and DNA single strand breaks induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and its analogues in primary culture of rat hepatocytes Cancer Research. 50: 1810-1816. PMID 2306734 |
0.148 |
|
| 1991 |
Liu L, Alaoui-Jamali MA, el Alami N, Castonguay A. Characterization of activation and deactivation pathways of 4-(N-nitrosomethylamino)-1-(3-pyridyl)-1-butanone (NNK) in rat hepatocytes Iarc Scientific Publications. 510-515. PMID 1855907 |
0.147 |
|
| 2024 |
Guo Q, Li VZ, Nichol JN, Huang F, Yang W, Preston SEJ, Talat Z, Lefrère H, Yu H, Zhang G, Basik M, Gonçalves C, Zhan Y, Plourde D, Su J, ... ... Alaoui-Jamali M, et al. Correction: MNK1/NODAL Signaling Promotes Invasive Progression of Breast Ductal Carcinoma In Situ. Cancer Research. 84: 1373. PMID 38616659 DOI: 10.1158/0008-5472.CAN-24-0461 |
0.145 |
|
| 1989 |
Rossignol G, Alaoui-Jamali MA, Castonguay A, Schuller HM. Metabolism and DNA damage induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in fetal tissues of the Syrian golden hamster Cancer Research. 49: 5671-5676. PMID 2790785 |
0.138 |
|
| 2024 |
Zhan Y, Guo J, Yang W, Goncalves C, Rzymski T, Dreas A, Żyłkiewicz E, Mikulski M, Brzózka K, Golas A, Kong Y, Ma M, Huang F, Huor B, Guo Q, ... ... Alaoui-Jamali MA, et al. MNK1/2 inhibition limits oncogenicity and metastasis of KIT-mutant melanoma. The Journal of Clinical Investigation. 134. PMID 38618965 DOI: 10.1172/JCI181338 |
0.137 |
|
| 2023 |
Atique M, Muniz I, Farshadi F, Hier M, Mlynarek A, Macarella M, Maschietto M, Nicolau B, Alaoui-Jamali MA, da Silva SD. Genetic Mutations Associated with Inflammatory Response Caused by HPV Integration in Oropharyngeal Squamous Cell Carcinoma. Biomedicines. 12. PMID 38275384 DOI: 10.3390/biomedicines12010024 |
0.133 |
|
| 2017 |
Lubov J, Maschietto M, Ibrahim I, Mlynarek A, Hier M, Kowalski LP, Alaoui-Jamali MA, da Silva SD. Meta-analysis of micrornas expression in head and neck cancer: uncovering association with outcome and mechanisms. Oncotarget. PMID 28732368 DOI: 10.18632/oncotarget.19224 |
0.133 |
|
| 2020 |
de Lima JM, Bonan PR, da Cruz Perez DE, Hier M, Alaoui-Jamali MA, da Silva SD. Nanoparticle-Based Chemotherapy Formulations for Head and Neck Cancer: A Systematic Review and Perspectives. Nanomaterials (Basel, Switzerland). 10. PMID 33003387 DOI: 10.3390/nano10101938 |
0.124 |
|
| 2024 |
Muniz IAF, Araujo M, Bouassaly J, Farshadi F, Atique M, Esfahani K, Bonan PRF, Hier M, Mascarella M, Mlynarek A, Alaoui-Jamali M, Silva SDD. Therapeutic Advances and Challenges for the Management of HPV-Associated Oropharyngeal Cancer. International Journal of Molecular Sciences. 25. PMID 38612819 DOI: 10.3390/ijms25074009 |
0.12 |
|
| 2021 |
Klionsky DJ, Abdel-Aziz AK, Abdelfatah S, Abdellatif M, Abdoli A, Abel S, Abeliovich H, Abildgaard MH, Abudu YP, Acevedo-Arozena A, Adamopoulos IE, Adeli K, Adolph TE, Adornetto A, Aflaki E, ... ... Alaoui-Jamali MA, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition). Autophagy. 1-382. PMID 33634751 DOI: 10.1080/15548627.2020.1797280 |
0.114 |
|
| 2021 |
Li L, Guturi KKN, Gautreau B, Patel PS, Saad A, Morii M, Mateo F, Palomero L, Barbour H, Gomez A, Ng D, Kotlyar M, Pastrello C, Jackson HW, Khokha R, ... ... Alaoui-Jamali M, et al. Ubiquitin ligase RNF8 suppresses Notch signaling to regulate mammary development and tumorigenesis. The Journal of Clinical Investigation. 131. PMID 34196309 DOI: 10.1172/JCI152424 |
0.111 |
|
| 1989 |
Alaoui-Jamali MA, Rossignol G, Schuller HM, Castonguay A. Transplacental genotoxicity of a tobacco-specific N-nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, in Syrian golden hamster Mutation Research/Genetic Toxicology. 223: 65-72. PMID 2654630 DOI: 10.1016/0165-1218(89)90063-3 |
0.111 |
|
| 2022 |
Castellano LRC, Cruz SBSC, Hier M, Bonan PRF, Alaoui-Jamali MA, da Silva SD. Implications and Emerging Therapeutic Avenues of Inflammatory Response in HPV+ Head and Neck Squamous Cell Carcinoma. Cancers. 14. PMID 36358823 DOI: 10.3390/cancers14215406 |
0.109 |
|
| 2020 |
Kowalski LP, Coletta RD, Salo T, Maschietto M, Chojniak R, Lima JM, Mlynarek A, Hier MP, Alaoui-Jamali MA, Silva SD. Head and neck cancer: Emerging concepts in biomarker discovery and opportunities for clinical translation. Clinical and Translational Medicine. 10: e209. PMID 33252865 DOI: 10.1002/ctm2.209 |
0.108 |
|
| 2022 |
Morand GB, Diaconescu A, Ibrahim I, Lamarche G, Ruas JS, Dalfen J, Hier MP, Alaoui-Jamali MA, Maschietto M, da Silva SD. Molecular prognostic indicators in HPV-positive oropharyngeal cancer: an updated review. Clinical & Experimental Metastasis. PMID 35084607 DOI: 10.1007/s10585-022-10148-9 |
0.106 |
|
| 2024 |
Bouassaly J, Karimi N, Kowalski LP, Sultanem K, Alaoui-Jamali M, Mlyanarek A, Mascarella M, Hier M, Sadeghi N, da Silva SD. Rethinking Treatment Paradigms: Neoadjuvant Therapy and De-Escalation Strategies in HPV-Positive Head and Neck Cancer. Critical Reviews in Oncology/Hematology. 104326. PMID 38479584 DOI: 10.1016/j.critrevonc.2024.104326 |
0.106 |
|
| 1994 |
Lehnert S, Alaoui-Jamali M, Batist G. Factors influencing human tumor radioresistance Journal De Chimie Physique. 91: 1161-1175. DOI: 10.1051/jcp/1994911161 |
0.098 |
|
| 2015 |
Alaoui-Jamali M. Comment on "p38 MAPK inhibition alleviates experimental acute pancreatitis in mice". Hepatobiliary & Pancreatic Diseases International : Hbpd Int. 14: 330. PMID 26063037 DOI: 10.1016/S1499-3872(15)60366-6 |
0.081 |
|
| 2022 |
Morand GB, Cardona I, Cruz SBSC, Mlynarek AM, Hier MP, Alaoui-Jamali MA, da Silva SD. Therapeutic Vaccines for HPV-Associated Oropharyngeal and Cervical Cancer: The Next De-Intensification Strategy? International Journal of Molecular Sciences. 23. PMID 35955529 DOI: 10.3390/ijms23158395 |
0.077 |
|
| 1986 |
Alaoui-Jamali MA, Nguyen PL, Chouroulinkov I, Truhaut R. Preliminary study on the toxicity of new cytostatic drugs: Ketonucleosides Comptes Rendus De L'Academie Des Sciences - Serie Iii. 303: 161-165. |
0.063 |
|
| 2012 |
Zhang P, Sun X, Xu B, Bijian K, Wan S, Li G, Alaoui-Jamali M, Jiang T. ChemInform Abstract: Total Synthesis and Bioactivity of the Marine Alkaloid Pityriacitrin and Some of Its Derivatives. Cheminform. 43: no-no. DOI: 10.1002/chin.201215202 |
0.057 |
|
| Hide low-probability matches. |